1. 1 ICON Quarter 2, 2009 Results ended June 30, 2009 Dr. John Climax, Chairman Mr. Peter Gray, CEO Mr. Ciaran Murray, CFO

2. 2 Certain statements contained herein including, without limitation, statements containing the words “believes,” “anticipates,” “intends,” “expects” and words of similar import, constitute forward-looking statements concerning the Company's operations, performance, financial condition and prospects. Because such statements involve known and unknown risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This presentation includes selected non-GAAP financial measures. For a presentation of the most directly comparable GAAP financial measures, please refer to the press release consolidated income statement headed Consolidated Income Statements (Unaudited) (US GAAP) Forward Looking Statement

3. 3 Quarterly Net Revenue Growth

4. 4 Quarterly Operating Income

5. 5 Operating Margins (After charging non-cash stock compensation expense (SFAS123R))

6. 6 Quarterly Earnings per Share and Net Income

7. 7 Quarter ended June 30, 2009 Quarter ended March 31, 2009 Year ended Dec 31, 2008 Cash from operating activities 103.024.781.3 Capital Expenditure 8.38.167.9 Net Cash / (Debt) 83.2(2.2)(4.3) Net Accounts Receivable 163.6210.3230.3 DSOs49 days59 Days69 Days Balance Sheet $ million

8. 8  Outlook

9. 9 Business Wins

10. 10 Total Backlog

11. 11 Backlog forecast to be earned in the next 12 months (US$ & % of total forecasts)

12. 12 Guidance updated Prior Guidance Implied Q1 UpdateUpdated Guidance (issued 9th Jan 09) (issued 22nd July 09) Revenue$930 - $980 m$930 m$880 - $900 m EPS$1.40 - $1.52$1.40$1.38 - $1.44 Omaha Dilutive Impact (0.04 - 0.06c) Implied Guidance $1.34 - $ 1.36

13. 13 Questions & Answers Dr John Climax, Chairman Mr Peter Gray, CEO Mr Ciaran Murray, CFO

14. 14 Q2 income from operations ↑ 20% Q2 Operating margin of 13.3% Q2 EPS ↑ 22% Net cash of $83.2 million, Q2 v $2.2m of net debt, Q1 Book-to-bill ratio 1.2 Summary Quarter 2, 2009